Biden's Successor: The Radical Threat to YOUR Savings!

Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.

>> Get Your FREE Wealth Protection Guide <<

TEVA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.55%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $14,909,765.00

Teva Pharmaceutical Industries Insider Trading History Chart

Teva Pharmaceutical Industries Share Price & Price History

^$17.75

▼ -0.13 (-0.73%)

As of 09/19/2024 12:59 PM ET

Days: 30 | 90 | 365

Unveiled: NVIDIA’s "Secret Royalty" Program

From Behind the Markets | Ad

Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?

Click Here to learn how to get in now >>>

Teva Pharmaceutical Industries Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2024	Eric A Hughes	Insider	Sell	24,537	$17.25	$423,263.25	45,060
6/18/2024	Roberto Mignone	Director	Sell	519,000	$17.03	$8,838,570.00	981,000
5/15/2024	Amir Weiss	CAO	Sell	15,500	$16.80	$260,400.00	17,814
5/13/2024	Vikki L. Conway	Insider	Sell	15,219	$16.74	$254,766.06
3/5/2024	Mark Sabag	EVP	Sell	100,000	$13.52	$1,352,000.00	382,590
2/28/2024	Eric Drape	VP	Sell	9,815	$13.12	$128,772.80	9,701
2/28/2024	Vikki L. Conway	Insider	Sell	1,366	$13.12	$17,921.92	2,928
2/16/2024	Eric Drape	VP	Sell	173,261	$13.05	$2,261,056.05	1
2/15/2024	Richard D. Francis	CEO	Sell	74,530	$13.15	$980,069.50	87,125
2/1/2024	Amir Weiss	CAO	Sell	31,766	$12.37	$392,945.42	10,676
8/7/2023	Eliyahu Sharon Kalif	CFO	Sell	35,125	$9.73	$341,766.25	99,162
8/4/2023	Amir Weiss	CAO	Sell	1,981	$9.92	$19,651.52	42,442
8/1/2023	Eric A. Hughes	insider	Sell	52,742	$8.30	$437,758.60
3/6/2023	David Matthew Stark	VP	Sell	16,491	$9.93	$163,755.63	52,449
3/6/2023	Sven Dethlefs	EVP	Sell	19,355	$9.93	$192,195.15	223,447
2/28/2023	David Matthew Stark	VP	Sell	63,383	$9.89	$626,857.87	2,974
2/28/2023	Sven Dethlefs	EVP	Sell	59,655	$9.89	$589,987.95	165,381
8/22/2022	Eliyahu Sharon Kalif	CFO	Sell	55,500	$10.07	$558,885.00	9,376
7/28/2022	David Matthew Stark	VP	Sell	58,163	$9.04	$525,793.52	2,974
5/17/2022	Hafrun Fridriksdottir	VP	Sell	130,000	$8.22	$1,068,600.00	1,387
2/28/2022	David Matthew Stark	VP	Sell	6,452	$8.14	$52,519.28
2/28/2022	Eli Shani	EVP	Sell	5,311	$8.14	$43,231.54
2/9/2022	David Matthew Stark	VP	Sell	6,110	$9.06	$55,356.60
2/9/2022	Sven Dethlefs	EVP	Sell	4,138	$9.06	$37,490.28

War on Elon Escalates…

From Porter & Company | Ad

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

SEC Filings (Institutional Ownership Changes) for Teva Pharmaceutical Industries (NYSE:TEVA)

54.05% of Teva Pharmaceutical Industries stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Teva Pharmaceutical Industries Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/5/2024	Sanctuary Advisors LLC	34,465	$0.56M	0.0%	N/A	0.003%
8/22/2024	Cetera Investment Advisers	60,868	$0.99M	0.0%	+83.9%	0.005%
8/21/2024	Truist Financial Corp	3,885,251	$63.14M	0.1%	+7.0%	0.343%
8/19/2024	Point72 Asset Management L.P.	1,319,217	$21.44M	0.1%	+38.0%	0.116%
8/16/2024	Creative Planning	40,952	$0.67M	0.0%	-1.4%	0.004%
8/16/2024	Driehaus Capital Management LLC	1,422,483	$23.12M	0.2%	N/A	0.126%
8/15/2024	Lighthouse Investment Partners LLC	420,000	$6.83M	0.3%	N/A	0.037%
8/15/2024	Mackenzie Financial Corp	42,318	$0.69M	0.0%	-55.5%	0.004%
8/15/2024	The Manufacturers Life Insurance Company	408,154	$6.63M	0.0%	-1.0%	0.036%
8/15/2024	Maverick Capital Ltd.	65,483	$1.06M	0.0%	+13.8%	0.006%
8/15/2024	MBB Public Markets I LLC	78,598	$1.28M	0.0%	+413.0%	0.007%
8/15/2024	Eminence Capital LP	1,000,000	$16.25M	0.3%	N/A	0.088%
8/15/2024	APG Asset Management N.V.	1,269,396	$19.25M	0.0%	+9.7%	0.112%
8/15/2024	APG Asset Management US Inc.	319,739	$5.23M	0.0%	+2.5%	0.028%
8/15/2024	AQR Capital Management LLC	16,144	$0.26M	0.0%	N/A	0.001%
8/15/2024	Caxton Associates LP	29,707	$0.48M	0.0%	N/A	0.003%
8/15/2024	Point72 Hong Kong Ltd	5,162	$84K	0.0%	N/A	0.000%
8/15/2024	Toronto Dominion Bank	20,704	$0.34M	0.0%	+17,298.3%	0.002%
8/14/2024	Point72 Asset Management L.P.	1,319,217	$21.44M	0.1%	+38.0%	0.116%
8/14/2024	Cubist Systematic Strategies LLC	116,569	$1.89M	0.0%	-68.4%	0.010%
8/14/2024	Marshall Wace LLP	4,172,593	$67.81M	0.1%	-1.0%	0.368%
8/14/2024	Tri Locum Partners LP	2,550,307	$41.44M	10.5%	+15.1%	0.225%
8/14/2024	Davidson Kempner Capital Management LP	1,765,485	$28.69M	0.6%	+152.5%	0.156%
8/14/2024	Bank of Montreal Can	413,759	$6.83M	0.0%	+16.8%	0.037%
8/14/2024	Public Sector Pension Investment Board	470,667	$7.65M	0.0%	+5.8%	0.042%
8/14/2024	Altshuler Shaham Ltd	277,920	$4.53M	0.2%	+12.3%	0.025%
8/14/2024	Continental Advisors LLC	403,766	$6.56M	2.9%	-15.5%	0.036%
8/14/2024	HighVista Strategies LLC	136,500	$2.22M	0.8%	N/A	0.012%
8/14/2024	Gabelli Funds LLC	50,000	$0.81M	0.0%	+56.3%	0.004%
8/13/2024	Rubric Capital Management LP	17,261,741	$280.50M	7.4%	-2.3%	1.524%
8/13/2024	Thrivent Financial for Lutherans	184,293	$3M	0.0%	+44.1%	0.016%
8/13/2024	Sound Shore Management Inc. CT	6,761,446	$109.87M	3.7%	-9.8%	0.597%
8/13/2024	Sei Investments Co.	444,381	$7.22M	0.0%	-2.8%	0.039%
8/13/2024	AE Wealth Management LLC	198,808	$3.23M	0.0%	+29.0%	0.018%
8/13/2024	Public Employees Retirement Association of Colorado	237,226	$3.86M	0.0%	-4.9%	0.021%
8/12/2024	XTX Topco Ltd	67,068	$1.09M	0.1%	-13.5%	0.006%
8/12/2024	Mark Sheptoff Financial Planning LLC	3,500	$57K	0.0%	N/A	0.000%
8/12/2024	Seven Eight Capital LP	85,154	$1.38M	0.1%	N/A	0.008%
8/12/2024	Hsbc Holdings PLC	758,405	$12.37M	0.0%	-49.1%	0.067%
8/12/2024	Vanguard Personalized Indexing Management LLC	27,643	$0.45M	0.0%	+26.7%	0.002%
8/12/2024	Lingotto Investment Management LLP	26,462,600	$430.02M	14.4%	+0.1%	2.336%
8/10/2024	Sargent Investment Group LLC	122,580	$1.99M	0.4%	-1.6%	0.011%
8/9/2024	Renaissance Technologies LLC	8,728,563	$141.84M	0.2%	+13.4%	0.771%
8/9/2024	Dimensional Fund Advisors LP	1,466,704	$23.83M	0.0%	+23.1%	0.129%
8/9/2024	Capital Wealth Planning LLC	161,350	$2.62M	0.0%	+5.0%	0.014%
8/8/2024	Alta Advisers Ltd	4,500	$73K	0.0%	N/A	0.000%
8/8/2024	Envestnet Asset Management Inc.	2,076,600	$33.75M	0.0%	+11.1%	0.183%
8/8/2024	Thoroughbred Financial Services LLC	17,592	$0.29M	0.0%	+14.3%	0.002%
8/8/2024	Dai ichi Life Insurance Company Ltd	52,146	$0.85M	0.0%	+5.5%	0.005%
8/8/2024	DekaBank Deutsche Girozentrale	78,319	$1.26M	0.0%	+8.6%	0.007%
8/8/2024	AIMZ Investment Advisors LLC	229,324	$3.73M	1.3%	-1.5%	0.020%
8/8/2024	Cornercap Investment Counsel Inc.	64,514	$1.05M	0.2%	N/A	0.006%
8/8/2024	Achmea Investment Management B.V.	587,188	$9.54M	0.2%	+4.6%	0.052%
8/8/2024	Y.D. More Investments Ltd	105,500	$1.71M	0.2%	+7.0%	0.009%
8/8/2024	American Century Companies Inc.	175,178	$2.85M	0.0%	+12.9%	0.015%
8/8/2024	State of New Jersey Common Pension Fund D	456,809	$7.42M	0.0%	-32.4%	0.040%
8/7/2024	ClariVest Asset Management LLC	600,816	$9.76M	1.0%	+1.7%	0.053%
8/7/2024	Headlands Technologies LLC	11,493	$0.19M	0.0%	-24.4%	0.001%
8/7/2024	Daiwa Securities Group Inc.	81,365	$1.32M	0.0%	-29.7%	0.007%
8/7/2024	Monaco Asset Management SAM	475,000	$7.72M	1.2%	-65.2%	0.042%
8/7/2024	United Services Automobile Association	41,159	$0.67M	0.0%	+3.1%	0.004%
8/7/2024	Wedbush Securities Inc.	28,404	$0.46M	0.0%	-10.8%	0.003%
8/7/2024	PFG Investments LLC	17,435	$0.28M	0.0%	-8.4%	0.002%
8/6/2024	Private Management Group Inc.	1,375,431	$22.35M	0.9%	-6.3%	0.121%
8/6/2024	Emerald Advisers LLC	86,747	$1.41M	0.1%	-16.2%	0.008%
8/6/2024	Caprock Group LLC	132,302	$2.15M	0.1%	N/A	0.012%
8/6/2024	Acadian Asset Management LLC	1,124,749	$18.26M	0.1%	+90.8%	0.099%
8/5/2024	Victory Capital Management Inc.	1,906,951	$30.99M	0.0%	+6.0%	0.168%
8/3/2024	Range Financial Group LLC	61,777	$1M	0.5%	+9.3%	0.005%
8/3/2024	TD Asset Management Inc	225,109	$3.66M	0.0%	+1.2%	0.020%
8/1/2024	Rhumbline Advisers	338,655	$5.50M	0.0%	-0.7%	0.030%
8/1/2024	CIBC Asset Management Inc	99,750	$1.62M	0.0%	+3.4%	0.009%
8/1/2024	Natixis Advisors LLC	201,352	$3.27M	0.0%	+27.5%	0.018%
8/1/2024	Ritholtz Wealth Management	11,269	$0.18M	0.0%	N/A	0.001%
7/31/2024	Picton Mahoney Asset Management	198,500	$3.23M	0.1%	N/A	0.018%
7/31/2024	Van ECK Associates Corp	1,666,714	$27.08M	0.0%	+7.7%	0.147%
7/31/2024	Commonwealth Equity Services LLC	162,770	$2.65M	0.0%	-39.8%	0.014%
7/30/2024	Forum Financial Management LP	10,570	$0.17M	0.0%	-8.6%	0.001%
7/30/2024	Sumitomo Mitsui DS Asset Management Company Ltd	105,175	$1.71M	0.0%	+10.4%	0.009%
7/30/2024	iA Global Asset Management Inc.	419,075	$6.81M	0.1%	+311.9%	0.037%
7/30/2024	Sivik Global Healthcare LLC	200,000	$3.25M	1.2%	+14.3%	0.018%
7/29/2024	Hara Capital LLC	32,810	$0.53M	0.3%	N/A	0.003%
7/29/2024	Principal Financial Group Inc.	107,416	$1.75M	0.0%	-7.0%	0.009%
7/29/2024	Panagora Asset Management Inc.	125,270	$2.04M	0.0%	-69.8%	0.011%
7/29/2024	Argyle Capital Management Inc.	16,200	$0.26M	0.1%	-8.0%	0.001%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	438,879	$7.13M	0.0%	+2.9%	0.039%
7/29/2024	Bfsg LLC	13,405	$0.22M	0.0%	-8.7%	0.001%
7/29/2024	Migdal Insurance & Financial Holdings Ltd.	29,118,210	$473.17M	7.9%	-2.5%	2.571%
7/26/2024	WealthShield Partners LLC	15,000	$0.24M	0.0%	N/A	0.001%
7/26/2024	AustralianSuper Pty Ltd	8,505,102	$138.21M	0.8%	-15.9%	0.751%
7/26/2024	ARK Investment Management LLC	169,420	$2.75M	0.0%	-11.8%	0.015%
7/26/2024	Summit Securities Group LLC	22,500	$0.37M	0.1%	N/A	0.002%
7/26/2024	Allspring Global Investments Holdings LLC	62,410	$1.01M	0.0%	+69.8%	0.006%
7/26/2024	Bank of New York Mellon Corp	1,602,213	$26.04M	0.0%	-2.0%	0.141%
7/23/2024	Hennessy Advisors Inc.	603,900	$9.81M	0.4%	N/A	0.053%
7/23/2024	Byrne Asset Management LLC	3,210	$52K	0.0%	N/A	0.000%
7/22/2024	Harel Insurance Investments & Financial Services Ltd.	19,208	$0.31M	0.0%	-25.4%	0.002%
7/20/2024	Hennion & Walsh Asset Management Inc.	289,279	$4.70M	0.2%	+40.3%	0.026%
7/20/2024	Zhang Financial LLC	19,000	$0.31M	0.0%	-26.9%	0.002%
7/19/2024	Raymond James & Associates	815,944	$13.26M	0.0%	+5.1%	0.072%

Data available starting January 2016

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Today's Range

Now: $17.75

$17.69

$18.11

50 Day Range

MA: $17.65

$16.34

$18.97

52 Week Range

Now: $17.75

$8.06

$19.08

Volume

2,235,313 shs

Average Volume

9,913,456 shs

Market Capitalization

$20.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88

Who are the company insiders with the largest holdings of Teva Pharmaceutical Industries?: Teva Pharmaceutical Industries' top insider investors include:
Roberto Mignone (Director)
Mark Sabag (EVP)
Sven Dethlefs (EVP)
Eliyahu Sharon Kalif (CFO)
Richard D Francis (CEO)
David Matthew Stark (VP)
Eric A Hughes (Insider)
Amir Weiss (CAO)
Eric Drape (VP)
Vikki L Conway (Insider)
Eric A Hughes (Insider)
Vikki L Conway (Insider)
Learn More about top insider investors at Teva Pharmaceutical Industries.
Who are the major institutional investors of Teva Pharmaceutical Industries?: Teva Pharmaceutical Industries' top institutional investors include:
Migdal Insurance & Financial Holdings Ltd. — 2.57%
Lingotto Investment Management LLP — 2.34%
Rubric Capital Management LP — 1.52%
Renaissance Technologies LLC — 0.77%
AustralianSuper Pty Ltd — 0.75%
Sound Shore Management Inc. CT — 0.60%
Learn More about top institutional investors of Teva Pharmaceutical Industries stock.
Which institutional investors are selling Teva Pharmaceutical Industries stock?: During the previous quarter, TEVA stock was sold by these institutional investors:
Susquehanna International Group LLP
AustralianSuper Pty Ltd
Monaco Asset Management SAM
Migdal Insurance & Financial Holdings Ltd.
Sound Shore Management Inc. CT
Hsbc Holdings PLC
Assenagon Asset Management S.A.
Rubric Capital Management LP
In the previous year, company insiders that have sold Teva Pharmaceutical Industries company stock include:
Roberto Mignone (Director)
Mark Sabag (EVP)
Sven Dethlefs (EVP)
Eliyahu Sharon Kalif (CFO)
Richard D Francis (CEO)
David Matthew Stark (VP)
Eric A Hughes (Insider)
Amir Weiss (CAO)
Learn More investors selling Teva Pharmaceutical Industries stock.
Which institutional investors are buying Teva Pharmaceutical Industries stock?: Within the last quarter, TEVA stock was acquired by institutional investors including:
Driehaus Capital Management LLC
Davidson Kempner Capital Management LP
Renaissance Technologies LLC
Eminence Capital LP
Hennessy Advisors Inc.
Acadian Asset Management LLC
Lighthouse Investment Partners LLC
Point72 Asset Management L.P.